Notably, patients with stage IV cancer showed a trend toward a higher baseline L-Dex (3.9 versus −0.3 to +0.1), although this represented only 1% of the population.
← all excerpts
The Importance of a Pre-treatment Baseline When Screening Patients for Breast-Cancer-Related Lymphedema.
1
—
—